Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant, AZ Achieve Milestone in Neuroscience Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Jubilant, AZ Achieve Milestone in Neuroscience Pact

Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant Biosys Ltd., a subsidiary of Jubilant Life Sciences Ltd., has successfully completed an early stage milestone in its neuroscience collaboration with AstraZeneca in the pain therapeutic area.

The collaboration, under which Jubilant aims to provide a steady stream of preclinical outcomes to AstraZeneca, has now expanded to include cardiovascular and metabolic diseases. AstraZeneca owns the compounds developed under the collaboration with worldwide development and commercialization rights. Jubilant receives research funding and success-based development and commercialization milestones.

Sri Mosur, chief executive officer and president, Global Drug Discovery & Development, Jubilant said, “We are pleased that we have delivered outcomes and early success to the portfolio efforts at AstraZeneca. This is the result of excellent collaboration between scientists at Jubilant and AstraZeneca.”

“Partnering is a strategic priority for AstraZeneca at all stages of drug discovery and development,” said Christof Angst, CNS & Pain Innovative Medicines, vice president, Strategy and Externalization at AZ. “By combining our strengths with those of our partners, we are in a better position to deliver new medicines that can make a meaningful difference to patients’ lives.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics